Based on these findings, and the experimental data supporting that the tauopathy is a secondary event of the autoimmune disorder [33, 34, 48], we suggest a classification into three pathological stages of the anti-IgLON5 disease-related tauopathy. Here, IGLON5 is linked to tauopathy.